Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Chronic Lymphocytic Leukemia

Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls

Abstract

Although the risk of progression from monoclonal B-cell lymphocytosis (MBL) to chronic lymphocytic leukemia (CLL) has been well characterized, it is unknown whether other common complications associated with CLL, such as increased risk of infection, occurs in individuals with MBL. We used the Mayo CLL database to identify cohorts of individuals with newly diagnosed MBL (n=154) or newly diagnosed CLL (n=174) who resided within 50 miles of Mayo Clinic. A cohort of 689 adult patients seen for a general medical examination who resided within 50 miles of Mayo clinic and who enrolled in a case–control study of non-Hodgkin lymphoma (NHL) was used as a comparison cohort. Hospitalization with infection was more common among individuals with MBL (25/154; 16.2%), and CLL (32/174; 18.4%) than controls (18/689; 2.6%). On pooled multivariable Cox proportional hazards analysis of all 1017 patients (controls, MBL and CLL), male sex (hazards ratio (HR)=2.3; P=0.002), major co-morbid health problems (HR=1.7, P=0.04), the presence of CLL (HR=3.2, P<0.001), treatment for progressive CLL (HR=2.4, P=0.001) and the presence of MBL (HR=3.0, P=0.001) were independently associated with risk of hospitalization for infection. These results suggest the risk of serious infection in clinical MBL is substantially greater than the risk of progression requiring treatment.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, Kay N et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005; 130: 325–332.

    Article  Google Scholar 

  2. Shanafelt TD, Ghia P, Lanasa MC, Landgren O, Rawstron AC. . Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia 2010; 24: 512–520.

    Article  CAS  Google Scholar 

  3. Rawstron A, Green M, Kuzmicki A, Kennedy B, Fenton J, Evans P et al. Monoclonal B lymphocytes with the characteristics of ‘indolent’ chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002; 100: 635–639.

    Article  CAS  Google Scholar 

  4. Ghia P, Prato G, Scielzo C, Stella S, Geuna M, Guida G et al. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood 2004; 103: 2337–2342.

    Article  CAS  Google Scholar 

  5. Rawstron AC, Shanafelt T, Lanasa MC, Landgren O, Hanson C, Orfao A et al. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B Clin Cytom 2010; 78 (Suppl 1): S19–S23.

    Article  Google Scholar 

  6. Rawstron AC, Bennett FL, O'Connor SJ, Kwok M, Fenton JA, Plummer M et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008; 359: 575–583.

    Article  CAS  Google Scholar 

  7. Shanafelt T, Kay N, Rabe K, Call T, Zent CS, Maddocks K et al. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis (MBL) compared to patients with Rai 0 chronic lymphocytic leukemia (CLL). J Clin Oncol 2009; 27: 3959–3963.

    Article  Google Scholar 

  8. Morrison VA . Management of infectious complications in patients with chronic lymphocytic leukemia. Hematol Am Soc Hematol Educ Program 2007; 2007: 332–338.

    Article  Google Scholar 

  9. Francis S, Karanth M, Pratt G, Starczynski J, Hooper L, Fegan C et al. The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia. Cancer 2006; 107: 1023–1033.

    Article  CAS  Google Scholar 

  10. Anderson LA, Landgren O, Engels EA . Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia. Br J Haematol 2009; 147: 444–449.

    Article  Google Scholar 

  11. Landgren O, Rapkin JS, Caporaso NE, Mellemkjaer L, Gridley G, Goldin LR et al. Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood 2007; 109: 2198–2201.

    Article  CAS  Google Scholar 

  12. Landgren O, Gridley G, Check D, Caporaso NE, Morris Brown L . Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia. Br J Haematol 2007; 139: 791–798.

    Article  Google Scholar 

  13. Cerhan JR, Fredericksen ZS, Wang AH, Habermann TM, Kay NE, Macon WR et al. Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. Int J Mol Epidemiol Genet 2011; 2: 95–113.

    PubMed  PubMed Central  Google Scholar 

  14. Thurmes P, Call T, Slager S, Zent C, Jenkins G, Schwager S et al. Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia. Leuk Lymphoma 2008; 49: 49–56.

    Article  Google Scholar 

  15. Bergstralh E, Offord K, Kosanke J, Augustine G . PERSONYRS: A SAS Procedure for Person-Years Analyses. SAS Institute Inc: Cary, NC, 1986.

    Google Scholar 

  16. Rossi D, Sozzi E, Puma A, De Paoli L, Rasi S, Spina V et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol 2009; 146: 64–75.

    Article  Google Scholar 

  17. Wadhwa PD, Morrison VA . Infectious complications of chronic lymphocytic leukemia. Semin Oncol 2006; 33: 240–249.

    Article  CAS  Google Scholar 

  18. Tsai HT, Caporaso NE, Kyle RA, Katzmann JA, Dispenzieri A, Hayes RB et al. Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study. Blood 2009; 114: 4928–4932.

    Article  CAS  Google Scholar 

  19. Levi F, Randimbison L, Te VC, La Vecchia C . Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996; 74: 1847–1850.

    Article  CAS  Google Scholar 

  20. Travis LB, Curtis RE, Hankey BF, Fraumeni JF . Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1992; 84: 1422–1427.

    Article  CAS  Google Scholar 

  21. Tsimberidou AM, Wen S, McLaughlin P, O'Brien S, Wierda WG, Lerner S et al. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol 2009; 27: 904–910.

    Article  Google Scholar 

  22. Royle JA, Baade PD, Joske D, Girschik J, Fritschi L . Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study. Br J Cancer 2011; 105: 1076–1081.

    Article  CAS  Google Scholar 

  23. Zent CS, Ding W, Reinalda MS, Schwager SM, Hoyer JD, Bowen DA et al. Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis. LeukLymphoma 2009; 50: 1261–1268.

    CAS  Google Scholar 

  24. Nieto WG, Almeida J, Romero A, Teodosio C, Lopez A, Henriques AF et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood 2009; 114: 33–37.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T D Shanafelt.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Author contributions

JM and TDS designed research, performed research, analyzed/interpreted data and wrote the manuscript. KGR and SLS designed research, performed research, analyzed/interpreted data and reviewed/edited the manuscript. JRC, NEK, JWW, TGC, JFL, DFJ and DAB analyzed/interpreted data and reviewed/edited the manuscript. SMS performed research and reviewed/edited the manuscript. CAH performed research, analyzed/interpreted data and reviewed/edited the manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moreira, J., Rabe, K., Cerhan, J. et al. Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls. Leukemia 27, 136–141 (2013). https://doi.org/10.1038/leu.2012.187

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2012.187

Keywords

This article is cited by

Search

Quick links